Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Ciurea

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Plos One|March 21, 2020
Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohortMonika Hebeisen, Raphael Micheroli, Almut Scherer, et al.
Clinical Rheumatology|December 27, 2022
HLA-B27 as a predictor of effectiveness of treatment with TNF inhibitors in axial spondyloarthritis: data from the Swiss Clinical Quality Management RegistryFabienne Fröhlich, Raphael Micheroli, Monika Hebeisen, et al.
Clinical Rheumatology|March 10, 2025
Anti-CD74 autoantibodies in axial spondyloarthritis as biomarkers for activity and severity of disease but not for tumour necrosis factor inhibitor retention: data from the Swiss Clinical Quality Management in rheumatic diseases cohortAnnik Steimer, Andrea Götschi, Torsten Witte, et al.
Annals of the Rheumatic Diseases|September 23, 2020
Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohortAdrian Ciurea, Eleftherios Papagiannoulis, Kristina Bürki, et al.
RMD Open|July 28, 2023
Impact of sex on spinal radiographic progression in axial spondyloarthritis: a longitudinal Swiss cohort analysis over a period of 10 yearsCaroline Ensslin, Raphael Micheroli, Seraphina Kissling, et al.
RMD Open|January 6, 2022
Role of synovial fibroblast subsets across synovial pathotypes in rheumatoid arthritis: a deconvolution analysisRaphael Micheroli, Muriel Elhai, Sam Edalat, et al.
Plos One|July 1, 2015
HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic RatsOsiris Marroquin Belaunzaran, Sascha Kleber, Stefan Schauer, et al.
Annals of the Rheumatic Diseases|August 1, 2019
Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohortsAnne Boel, Anna Molto, Désirée van der Heijde, et al.
RMD Open|February 3, 2022
Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohortAdrian Ciurea, Seraphina Kissling, Kristina Bürki, et al.
Clinical Rheumatology|June 8, 2023
Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management RegistryRaphael Micheroli, Seraphina Kissling, Kristina Bürki, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Plos One|March 21, 2020
Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohortMonika Hebeisen, Raphael Micheroli, Almut Scherer, et al.
Clinical Rheumatology|December 27, 2022
HLA-B27 as a predictor of effectiveness of treatment with TNF inhibitors in axial spondyloarthritis: data from the Swiss Clinical Quality Management RegistryFabienne Fröhlich, Raphael Micheroli, Monika Hebeisen, et al.
Clinical Rheumatology|March 10, 2025
Anti-CD74 autoantibodies in axial spondyloarthritis as biomarkers for activity and severity of disease but not for tumour necrosis factor inhibitor retention: data from the Swiss Clinical Quality Management in rheumatic diseases cohortAnnik Steimer, Andrea Götschi, Torsten Witte, et al.
Annals of the Rheumatic Diseases|September 23, 2020
Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohortAdrian Ciurea, Eleftherios Papagiannoulis, Kristina Bürki, et al.
RMD Open|July 28, 2023
Impact of sex on spinal radiographic progression in axial spondyloarthritis: a longitudinal Swiss cohort analysis over a period of 10 yearsCaroline Ensslin, Raphael Micheroli, Seraphina Kissling, et al.
RMD Open|January 6, 2022
Role of synovial fibroblast subsets across synovial pathotypes in rheumatoid arthritis: a deconvolution analysisRaphael Micheroli, Muriel Elhai, Sam Edalat, et al.
Plos One|July 1, 2015
HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic RatsOsiris Marroquin Belaunzaran, Sascha Kleber, Stefan Schauer, et al.
Annals of the Rheumatic Diseases|August 1, 2019
Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohortsAnne Boel, Anna Molto, Désirée van der Heijde, et al.
RMD Open|February 3, 2022
Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohortAdrian Ciurea, Seraphina Kissling, Kristina Bürki, et al.
Clinical Rheumatology|June 8, 2023
Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management RegistryRaphael Micheroli, Seraphina Kissling, Kristina Bürki, et al.
Pageof 13